Low anti-COVID-19 vaccination coverage and high COVID-19 mortality rates in Brazilian elderly

Detalhes bibliográficos
Autor(a) principal: Kupek, Emil
Data de Publicação: 2021
Tipo de documento: preprint
Idioma: eng
Título da fonte: SciELO Preprints
Texto Completo: https://preprints.scielo.org/index.php/scielo/preprint/view/2575
Resumo: Introduction: In 2021, Brazil started a nationwide vaccination against COVID-19 but the emergence of the P.1 variant of SARS-CoV-2, more transmissible and resistant to immunity from the previous infection, rapidly led to a record increase in COVID-19 mortality. Methods: Secondary data on COVID-19 deaths and vaccination coverage were retrieved to examine COVID-19 mortality rate (MR) evolution as anti-COVID-19 vaccination advanced in Brazil in 2021. Poisson regression with adjustment for age and federal states was used to calculate the MR. Results; By mid-April 2021, MR increased 2-3 times compared to the already high level in January for the people of 60 years or older, reaching the highest epidemic level of 5-15 per 100.000 in this age group. Despite a declining time trend followed, by the end of May, the MR level was still about 50% and 80% higher for the 40-79 and 80 years or older. The first dose of anti-COVID-19 coverage reached 80% for the 60-69 years old and exceeded 95% for those of 70 years or older, but the second dose was applied to only 26%, 76%, and 64% of the 60-69, 70-79, and 80 years or older, respectively. The average age-standardized MR over the study time was the highest in northern Brazilian states of Rondônia, Amazonas, Acre, and Roraima (range 6-8.4 per 100.000). Conclusion: Anti-COVID-19 vaccination coverage was below the level necessary to protect Brazilians from rising MR between January and May 2021. Urgent measures are needed to increase the vaccine supply and the adherence to non-pharmacological protective measures.
id SCI-1_7949b01b3fafa27fb7de1f62893e075b
oai_identifier_str oai:ops.preprints.scielo.org:preprint/2575
network_acronym_str SCI-1
network_name_str SciELO Preprints
repository_id_str
spelling Low anti-COVID-19 vaccination coverage and high COVID-19 mortality rates in Brazilian elderlyBaixa cobertura da vacina contra COVID-19 e altas taxas de mortalidade por COVID-19 em idosos no BrazilCOVID-19MortalidadeCobertura vacinalEstatística & dados numéricosBrasilCOVID-19MortalityVaccination coverageStatistics & numerical dataBrazilIntroduction: In 2021, Brazil started a nationwide vaccination against COVID-19 but the emergence of the P.1 variant of SARS-CoV-2, more transmissible and resistant to immunity from the previous infection, rapidly led to a record increase in COVID-19 mortality. Methods: Secondary data on COVID-19 deaths and vaccination coverage were retrieved to examine COVID-19 mortality rate (MR) evolution as anti-COVID-19 vaccination advanced in Brazil in 2021. Poisson regression with adjustment for age and federal states was used to calculate the MR. Results; By mid-April 2021, MR increased 2-3 times compared to the already high level in January for the people of 60 years or older, reaching the highest epidemic level of 5-15 per 100.000 in this age group. Despite a declining time trend followed, by the end of May, the MR level was still about 50% and 80% higher for the 40-79 and 80 years or older. The first dose of anti-COVID-19 coverage reached 80% for the 60-69 years old and exceeded 95% for those of 70 years or older, but the second dose was applied to only 26%, 76%, and 64% of the 60-69, 70-79, and 80 years or older, respectively. The average age-standardized MR over the study time was the highest in northern Brazilian states of Rondônia, Amazonas, Acre, and Roraima (range 6-8.4 per 100.000). Conclusion: Anti-COVID-19 vaccination coverage was below the level necessary to protect Brazilians from rising MR between January and May 2021. Urgent measures are needed to increase the vaccine supply and the adherence to non-pharmacological protective measures.Introdução: Brasil começou vacinar contra COVID-19 em 2021, mas o surgimento da variante P.1 do SARS-Cov-2, mais transmissível e resistente, rapidamente levou a aumento recorde em mortalidade por COVID-19. Métodos – Foram levantados dados secundários sobre mortes e cobertura vacinal relacionadas a COVID-19, para examinar a evolução da taxa de mortalidade (TM) com avanço da vacinação. Utilizou-se a regressão de Poisson com ajuste para idade e as unidades federadas. Resultados – Em abril, a TM aumentou 2-3 vezes comparado com começo do ano 2021 em pessoas com 60 ou mais anos de idade (60+), atingindo o nível recorde de 5-15 por 100.000. Apesar do subsequente declínio, no final de maio a taxa ainda estava aproximadamente 50% e 80% mais alta que no começo do ano para faixas etárias de 40-79 e 80+ anos, respectivamente. As pessoas com 70+ anos ultrapassaram a cobertura vacinal de 95%, enquanto aqueles de 60-69 anos chegaram à 80% da cobertura com a primeira dose da vacina. Porém, a segunda dose foi aplicada a somente 26%, 76%, e 64% das pessoas com 60-69, 70-79, e 80+ anos, respectivamente. As mais altas taxas de 6 a 8.4 per 100.000, ajustadas por faixa etária, foram registradas em Rondônia, Amazonas, Acre, e Roraima. Conclusão – Cobertura vacinal contra COVID-19 não atingiu os níveis necessários para proteger os Brasileiros contra crescente mortalidade por esta doença entre janeiro e maio de 2021. É preciso tomar medidas urgentes para aumentar o suprimento das vacinas e aderência às medidas preventivas não farmacológicas.SciELO PreprintsSciELO PreprintsSciELO Preprints2021-07-01info:eu-repo/semantics/preprintinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://preprints.scielo.org/index.php/scielo/preprint/view/257510.1590/1980-549720210041enghttps://preprints.scielo.org/index.php/scielo/article/view/2575/4457Copyright (c) 2021 Emil Kupekhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessKupek, Emilreponame:SciELO Preprintsinstname:SciELOinstacron:SCI2021-07-01T19:30:57Zoai:ops.preprints.scielo.org:preprint/2575Servidor de preprintshttps://preprints.scielo.org/index.php/scieloONGhttps://preprints.scielo.org/index.php/scielo/oaiscielo.submission@scielo.orgopendoar:2021-07-01T19:30:57SciELO Preprints - SciELOfalse
dc.title.none.fl_str_mv Low anti-COVID-19 vaccination coverage and high COVID-19 mortality rates in Brazilian elderly
Baixa cobertura da vacina contra COVID-19 e altas taxas de mortalidade por COVID-19 em idosos no Brazil
title Low anti-COVID-19 vaccination coverage and high COVID-19 mortality rates in Brazilian elderly
spellingShingle Low anti-COVID-19 vaccination coverage and high COVID-19 mortality rates in Brazilian elderly
Kupek, Emil
COVID-19
Mortalidade
Cobertura vacinal
Estatística & dados numéricos
Brasil
COVID-19
Mortality
Vaccination coverage
Statistics & numerical data
Brazil
title_short Low anti-COVID-19 vaccination coverage and high COVID-19 mortality rates in Brazilian elderly
title_full Low anti-COVID-19 vaccination coverage and high COVID-19 mortality rates in Brazilian elderly
title_fullStr Low anti-COVID-19 vaccination coverage and high COVID-19 mortality rates in Brazilian elderly
title_full_unstemmed Low anti-COVID-19 vaccination coverage and high COVID-19 mortality rates in Brazilian elderly
title_sort Low anti-COVID-19 vaccination coverage and high COVID-19 mortality rates in Brazilian elderly
author Kupek, Emil
author_facet Kupek, Emil
author_role author
dc.contributor.author.fl_str_mv Kupek, Emil
dc.subject.por.fl_str_mv COVID-19
Mortalidade
Cobertura vacinal
Estatística & dados numéricos
Brasil
COVID-19
Mortality
Vaccination coverage
Statistics & numerical data
Brazil
topic COVID-19
Mortalidade
Cobertura vacinal
Estatística & dados numéricos
Brasil
COVID-19
Mortality
Vaccination coverage
Statistics & numerical data
Brazil
description Introduction: In 2021, Brazil started a nationwide vaccination against COVID-19 but the emergence of the P.1 variant of SARS-CoV-2, more transmissible and resistant to immunity from the previous infection, rapidly led to a record increase in COVID-19 mortality. Methods: Secondary data on COVID-19 deaths and vaccination coverage were retrieved to examine COVID-19 mortality rate (MR) evolution as anti-COVID-19 vaccination advanced in Brazil in 2021. Poisson regression with adjustment for age and federal states was used to calculate the MR. Results; By mid-April 2021, MR increased 2-3 times compared to the already high level in January for the people of 60 years or older, reaching the highest epidemic level of 5-15 per 100.000 in this age group. Despite a declining time trend followed, by the end of May, the MR level was still about 50% and 80% higher for the 40-79 and 80 years or older. The first dose of anti-COVID-19 coverage reached 80% for the 60-69 years old and exceeded 95% for those of 70 years or older, but the second dose was applied to only 26%, 76%, and 64% of the 60-69, 70-79, and 80 years or older, respectively. The average age-standardized MR over the study time was the highest in northern Brazilian states of Rondônia, Amazonas, Acre, and Roraima (range 6-8.4 per 100.000). Conclusion: Anti-COVID-19 vaccination coverage was below the level necessary to protect Brazilians from rising MR between January and May 2021. Urgent measures are needed to increase the vaccine supply and the adherence to non-pharmacological protective measures.
publishDate 2021
dc.date.none.fl_str_mv 2021-07-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/preprint
info:eu-repo/semantics/publishedVersion
format preprint
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://preprints.scielo.org/index.php/scielo/preprint/view/2575
10.1590/1980-549720210041
url https://preprints.scielo.org/index.php/scielo/preprint/view/2575
identifier_str_mv 10.1590/1980-549720210041
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://preprints.scielo.org/index.php/scielo/article/view/2575/4457
dc.rights.driver.fl_str_mv Copyright (c) 2021 Emil Kupek
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2021 Emil Kupek
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv SciELO Preprints
SciELO Preprints
SciELO Preprints
publisher.none.fl_str_mv SciELO Preprints
SciELO Preprints
SciELO Preprints
dc.source.none.fl_str_mv reponame:SciELO Preprints
instname:SciELO
instacron:SCI
instname_str SciELO
instacron_str SCI
institution SCI
reponame_str SciELO Preprints
collection SciELO Preprints
repository.name.fl_str_mv SciELO Preprints - SciELO
repository.mail.fl_str_mv scielo.submission@scielo.org
_version_ 1797047823643967488